Stephanie Hufnagel Selected Research

Docosahexaenoyl difluorodeoxycytidine

1/2022

4-(N)-Docosahexaenoyl 2', 2'-difluorodeoxycytidine induces immunogenic cell death in colon and pancreatic carcinoma models as a single agent.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephanie Hufnagel Research Topics

Disease

4	Neoplasms (Cancer) 01/2022 - 02/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Bone Diseases (Bone Disease) 02/2019
1	Neoplasm Metastasis (Metastasis) 02/2019

Drug/Important Bio-Agent (IBA)

1	Docosahexaenoyl difluorodeoxycytidineIBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Lipid NanoparticlesIBA 01/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	Liposomes (Liposome)IBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Diphosphonates (Bisphosphonates)IBA 02/2019
1	Zoledronic Acid (Zometa)FDA Link 02/2019

Therapy/Procedure

1	Therapeutics 01/2022